Parallel Advisors, LLC Neogenomics Inc Transaction History
Parallel Advisors, LLC
- $4.18 Billion
- Q3 2024
A detailed history of Parallel Advisors, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 176 shares of NEO stock, worth $2,604. This represents 0.0% of its overall portfolio holdings.
Number of Shares
176
Previous 176
-0.0%
Holding current value
$2,604
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding NEO
# of Institutions
294Shares Held
124MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$291 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$208 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$102 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$97.7 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$96.8 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.86B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...